Polymer-Based Antibody Mimetics (iBodies) Target Human PD-L1 and Function as a Potent Immune Checkpoint Blocker

Scientists reported the development of polymer-based anti-human PD-L1 antibody mimetics by attaching the macrocyclic peptide WL12 to a N-(2-hydroxypropyl)methacrylamide copolymer.